Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Effects of dantrolene and verapamil on atrioventricular conduction and cardiovascular performance in dogs.

Lynch C 3rd, Durbin CG Jr, Fisher NA, Veselis RA, Althaus JS.

Anesth Analg. 1986 Mar;65(3):252-8.

PMID:
3954091
2.

Hyperkalemia and cardiovascular collapse after verapamil and dantrolene administration in swine.

Saltzman LS, Kates RA, Corke BC, Norfleet EA, Heath KR.

Anesth Analg. 1984 May;63(5):473-8.

PMID:
6711841
3.

Evaluation of combined administration of verapamil and disopyramide in dogs.

Lee JT, Davy JM, Kates RE.

J Cardiovasc Pharmacol. 1985 May-Jun;7(3):501-7.

PMID:
2410681
4.
5.

Cardiovascular action of verapamil in the dog with particular reference to myocardial contractility and atrioventricular conduction.

Angus JA, Richmond DR, Dhumma-Upakorn P, Cobbin LB, Goodman AH.

Cardiovasc Res. 1976 Nov;10(6):623-32.

PMID:
991162
6.

Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.

Millard RW, Lathrop DA, Grupp G, Ashraf M, Grupp IL, Schwartz A.

Am J Cardiol. 1982 Feb 18;49(3):499-506.

PMID:
6277175
7.
8.

Neuromuscular and electrocardiographic responses to verapamil in dogs.

Lawson NW, Kraynack BJ, Gintautas J.

Anesth Analg. 1983 Jan;62(1):50-4.

PMID:
6849509
9.

Hyperkalemia after dantrolene and verapamil-dantrolene administration in dogs.

San Juan AC Jr, Wong KC, Port JD.

Anesth Analg. 1988 Aug;67(8):759-62.

PMID:
3394963
10.

Bupivacaine accentuates the cardiovascular depressant effects of verapamil in conscious dogs.

Edouard A, Froidevaux R, Berdeaux A, Ahmad R, Samii K, Noviant Y.

Eur J Anaesthesiol. 1987 Jul;4(4):249-59.

PMID:
3653084
11.

Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations.

Mangiardi LM, Hariman RJ, McAllister RG Jr, Bhargava V, Surawicz B, Shabetai R.

Circulation. 1978 Feb;57(2):366-72.

PMID:
618628
12.

Effect of verapamil directly administered into A-V node artery on A-V junctional automaticity and A-V conduction in dogs.

Yano K, Hayano M, Kiya F, Fukatani M, Matsumoto Y, Mitsuoka T, Hashiba K.

J Cardiovasc Pharmacol. 1985 Nov-Dec;7(6):1027-33.

PMID:
2418284
13.

Comparative cardiovascular effects of verapamil, nifedipine, and diltiazem during halothane anesthesia in swine.

Kates RA, Zaggy AP, Norfleet EA, Heath KR.

Anesthesiology. 1984 Jul;61(1):10-8.

PMID:
6742468
14.

The influence of verapamil on dopamine's ability to augment cardiac output.

Sturm JT.

Ann Emerg Med. 1985 Oct;14(10):945-7.

PMID:
4037474
16.

Cardiovascular interactions of lidocaine with verapamil or diltiazem in the dog.

Kapur PA, Grogan DL, Fournier DJ.

Anesthesiology. 1988 Jan;68(1):79-85.

PMID:
3337393
17.

Cardiovascular and pharmacokinetic consequences of combined administration of verapamil and propranolol in dogs.

Hamann SR, Kaltenborn KE, Vore M, Tan TG, McAllister RG Jr.

Am J Cardiol. 1985 Jul 1;56(1):147-56.

PMID:
4014021
18.

Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.

Brown BS, Calzadilla SV, Diemer MJ, Hartman JC, Reynolds RD.

J Pharmacol Exp Ther. 1987 Dec;243(3):1225-34.

PMID:
3694532
19.

Systemic and coronary hemodynamic effects of repetitive cocaine administration in conscious dogs.

Pagel PS, Tessmer JP, Warltier DC.

J Cardiovasc Pharmacol. 1994 Sep;24(3):443-53.

PMID:
7528301

Supplemental Content

Support Center